Welcome To ChemAnalyst
US LABSA prices at DEL Houston rose 4.78% during the week of May 29, 2026, driven by a simultaneous 6.1% LAB feedstock surge, Stepan Company's June 1 price increase of $0.25–$0.27/lb for Sulfonic Acids, Sasol's extended force majeure creating extreme supply scarcity, and renewed US-Iran military strikes reinforcing Hormuz blockade persistence. Medium and small companies remain unable to source LABSA due to the acute shortage. With Sasol restart timing uncertain and Stepan increases transmitting through channels, prices are anticipated to record further sharp gains in upcoming weeks.
Linear Alkylbenzene Sulfonic Acid (LABSA) prices at DEL Houston surged 4.78% during the week ending May 29, 2026, as the extraordinary confluence of Stepan Company's sweeping June 1 surfactant price increase implementation, a simultaneous 6.1% weekly surge in US LAB feedstock pricing, Sasol's extended force majeure declaration, and renewed US-Iran military escalation produced the most acute LABSA supply-shortage pricing environment in modern US surfactant market history.
The dominant structural driver was the direct transmission of US LAB feedstock costs — which surged 6.1% during the same reference week — into LABSA production economics. Linear Alkylbenzene serves as the primary feedstock for LABSA production, representing 60–70% of total manufacturing costs, with sulfuric acid or oleum representing an additional 15–20%. The extraordinary 6.1% weekly LAB appreciation — itself driven by Sasol's force majeure and the concentration of European LAB supply on Cepsa as the sole remaining major producer — eliminated any residual margin buffer for US LABSA manufacturers, forcing immediate upward revision of DEL Houston offer pricing ahead of Stepan's formal June 1 price increase effective date.
Stepan Company's announcement proved a powerful immediate catalyst. The company raised list and off-list pricing for Sulfonic Acids including BIO-SOFT, POLYSTEP, and PETROSTEP brands by $0.25–$0.27 per pound, and Alkyl Benzene Sulfonates including NACCONOL and STEPWET by $0.06–$0.22 per pound — effective June 1, 2026 or as applicable contracts stipulate. Key LABSA manufacturers include Stepan, Cepsa, and Sasol as the dominant global producers; with Sasol's gas supply disruption-related shutdown eliminating production at its major LAB facilities since early March with uncertain restart timing, and Cepsa's European production concentrated on sustaining European supply, US downstream detergent manufacturers faced a critically tight LABSA spot availability environment. Market participants reported that medium-sized and small-scale companies were completely unable to source LABSA due to the acute shortage, with only large-scale producers able to procure at extraordinary cost premiums.
The geopolitical backdrop simultaneously re-intensified. Renewed US strikes on Iranian military sites and Iran's Revolutionary Guard retaliatory response drove crude oil prices sharply higher during the reference week, reinforcing expectations that the Strait of Hormuz blockade — which eliminated a critical source of Gulf LAB competitive supply — would persist well beyond previously anticipated diplomatic resolution timelines. Higher benzene and kerosene feedstock costs from Middle East tensions increased production expenses and pushed LABSA pricing upward, with port disruptions and constrained supply flows raising inland logistics costs throughout the conflict period.
On the demand side, the combination of Stepan's pre-announced price increase and extreme physical spot scarcity triggered emergency pre-buying by large US household cleaning, detergent, and personal care manufacturers who could still access supply — with buyers accelerating June procurement commitments into the final days of May to secure allocations before the formal June 1 price increase took effect. Looking ahead, US LABSA prices are anticipated to see further sharp increases in the coming weeks as the Sasol restart timeline remains uncertain and Stepan's June 1 price increases fully transmit through distribution channels.
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.
